CIK: 1329505 - Address: 601 Genome Way,, Suite 2001, Huntsville, AL 35806
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/31/24 16:18
5/29/24
SERSerina Therapeutics, Inc.ALHealthDrugPharmaceutical PreparationsBailey GregoryALDP.m619.50064620D
5/29/24 16:15
5/28/24
SERSerina Therapeutics, Inc.ALHealthDrugPharmaceutical PreparationsBailey GregoryALDP869.500918814D
5/24/24 16:15
5/21/24
SERSerina Therapeutics, Inc.ALHealthDrugPharmaceutical PreparationsBailey GregoryALDP.m319.50032165D
5/23/24 16:15
5/21/24
SERSerina Therapeutics, Inc.ALHealthDrugPharmaceutical PreparationsBailey GregoryALDP149.5001999%2D
5/22/24 16:15
5/20/24
SERSerina Therapeutics, Inc.ALHealthDrugPharmaceutical PreparationsBailey GregoryALDP19.0000New0D
5/15/24 07:31
5/13/24
BHVNBiohaven Ltd.D8HealthDrugPharmaceutical PreparationsBailey GregoryCTDP51334.1901511,615D
4/25/24 07:32
4/24/24
BHVNBiohaven Ltd.D8HealthDrugPharmaceutical PreparationsBailey GregoryCTDP99939.1802621,600D
4/23/24 07:54
4/22/24
BHVNBiohaven Ltd.D8HealthDrugPharmaceutical PreparationsBailey GregoryCTDP2,00041.0004931,575D
10/6/23 07:37
10/4/23
BHVNBiohaven Ltd.D8HealthDrugPharmaceutical PreparationsBailey GregoryCTDP40222.5701811,526D
10/26/22 18:22
10/25/22
BHVNBiohaven Ltd.D8HealthDrugPharmaceutical PreparationsBailey GregoryCTDP2,10010.500200151,508D
8/22/22 19:00
8/19/22
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsBailey GregoryCTDP5,626148.0403812,584D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact